Evaluation of the EasySense System in Congestive Heart Failure

CompletedOBSERVATIONAL
Enrollment

47

Participants

Timeline

Start Date

July 1, 2017

Primary Completion Date

June 30, 2019

Study Completion Date

June 30, 2020

Conditions
Congestive Heart Failure
Interventions
DEVICE

EasySense device

Implementation of EasySense device during hospitalization and daily post-discharge for thirty days.

Trial Locations (1)

43210

The Ohio State University Wexner Medical Center, Columbus

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

University of Memphis

OTHER

lead

Ohio State University

OTHER

NCT03237923 - Evaluation of the EasySense System in Congestive Heart Failure | Biotech Hunter | Biotech Hunter